Although each subtype is highly heterogeneous (2-5), hormone receptor positive (HR+) tumors comprise up to 70% to 80% of breast cancer cases and are driven by the estrogen receptor alpha (ERα, henceforth ER) transcription factor. Here, NR4A1 is linked to breast cancer.